Records containing: Prodromal Alzheimer's Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-06Alzheimer's Tau Platform (ATP): Regimen Specific Appendix for AADvac1
-
CLINICAL_TRIALS study record update · 2026-04-06The Alzheimer's Disease Tau Platform Clinical Trial
-
CLINICAL_TRIALS study record update · 2026-04-03Compensation Training to Improve Everyday Functioning of Older Adults With Mild Cognitive Impairment and Subjective Cognitive Complaints: The Digital Memory Notebook
-
CLINICAL_TRIALS study record update · 2026-01-09Role of the Gut-microbiota on Ageing and Neurodegeneration: a Clinical and Brain Imaging Study
-
CLINICAL_TRIALS study record update · 2025-12-15A Phase 1b/2, Multicenter, Adaptive, Double-blind, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, Immunogenicity, and Pharmacodynamic Effects of ACI-24.060 in Subjects With Prodromal Alzheimer's Disease and in Adults With Down Syndrome (ABATE)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-06-25A Randomized Trial of Financial Incentives for the Recruitment of County Health System Patients to the Alzheimer Prevention Trials (APT) Webstudy
-
CLINICAL_TRIALS study record update · 2025-06-12Combined Intervention Using Transcranial Direct Current Stimulation and Cognitive Training in Alzheimer's Type Dementia Patients
-
CLINICAL_TRIALS study record update · 2025-05-25A Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of AGB101 on Slowing Progression of Mild Cognitive Impairment Due to Alzheimer's Disease in Apolipoprotein E4 Non-carriers
-
CLINICAL_TRIALS study record update · 2025-04-23Partnered Rhythmic Rehabilitation for Enhanced Motor-Cognition in Prodromal Alzheimer's Disease
-
CLINICAL_TRIALS study record update · 2024-07-03Deferiprone to Delay Dementia (The 3D Study): a Clinical Proof of Concept Study
-
CLINICAL_TRIALS study record update · 2024-06-27Trial Ready Cohort for the Prevention of Alzheimer's Dementia (TRC-PAD)
-
CLINICAL_TRIALS study record update · 2024-06-14A Study to Evaluate the Ability of Speech- and Language-based Digital Biomarkers to Detect and Characterise Prodromal and Preclinical Alzheimer's Disease in a Clinical Setting - AMYPRED-US FUTURE Extension Study.
-
CLINICAL_TRIALS study record update · 2024-06-14A Study to Evaluate the Ability of Speech- and Language-based Digital Biomarkers to Detect and Characterise Prodromal and Preclinical Alzheimer's Disease in a Clinical Setting - FUTURE Extension Study.
-
CLINICAL_TRIALS study record update · 2024-05-17A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of AGB101on Slowing Progression of Mild Cognitive Impairment Due to Alzheimer's Disease
-
CLINICAL_TRIALS study record update · 2024-03-21Brain Iron Toxicity and Neurodegeneration - An Ultrahigh Field (7T) MRI Study
-
CLINICAL_TRIALS study record update · 2024-02-06Hyperbaric Oxygen Therapy for Prodromal Alzheimer´s Disease With Cerebrovascular Disease: A Prospective, Randomized, Double Blind Study
-
CLINICAL_TRIALS study record update · 2023-10-27COGNIFOOD-Investigating the Therapeutic Potential of Changing the Dietary Carbohydrate/Fat-ratio to Prevent Cognitive Decline and Alzheimer Pathology: A Pilot Study
-
CLINICAL_TRIALS study record update · 2022-04-07A Study to Evaluate the Ability of Speech- and Language-based Digital Biomarkers to Detect and Characterise Prodromal and Preclinical Alzheimer's Disease in a Clinical Setting - PAST Extension Study.
-
CLINICAL_TRIALS study record update · 2022-04-07A Study to Evaluate the Ability of Speech- and Language-based Digital Biomarkers to Detect and Characterise Prodromal and Preclinical Alzheimer's Disease in a Clinical Setting - AMYPRED-US PAST Extension Study
-
CLINICAL_TRIALS study record update · 2021-09-05A Study to Evaluate the Ability of Speech- and Language-based Digital Biomarkers to Detect and Characterise Prodromal and Preclinical Alzheimer's Disease in a Clinical Setting
-
CLINICAL_TRIALS study record update · 2021-09-05A Study to Evaluate the Ability of Speech- and Language-based Digital Biomarkers to Detect and Characterise Prodromal and Preclinical Alzheimer's Disease in a Clinical Setting
-
CLINICAL_TRIALS study record update · 2019-05-17A Phase III, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 (SCH 900931) in Subjects With Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal AD)
-
CLINICAL_TRIALS study record update · 2018-10-01A Two-Part, Open-Label Study to Investigate the Single-Dose Pharmacokinetics of MK-8931 When Administered to Subjects With Mild and Moderate Hepatic Insufficiency